ArticleInflammation and regeneration2024

Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis.

Haruka Tsuchiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.